
Was the emergence of intelligent life on Earth just a fluke? Some scientists think not
WASHINGTON, Feb 14 (Reuters) - Roughly 300,000 years ago, our species first appeared on the African landscape before spreading globally and coming to dominate the planet. All this happened about 4.5 billion years after Earth formed, with innumerable steps occurring in between that made our planet a cradle for intelligent life.
An influential scientific thesis - called the "hard steps" theory and first presented in 1983 - has held that this outcome was a long shot and that the emergence of technological-level intelligent life on Earth or elsewhere was highly improbable. But perhaps this result was not so unlikely after all, according to scientists who are now advancing an alternative theory.
These scientists propose that Homo sapiens and analogous extraterrestrial life forms may be the probable end result of biological and planetary evolution when a planet has a certain set of attributes that make it habitable, rather than requiring countless lucky breaks.
The path toward intelligent life, they argue, may be more of a predictable process, unfolding as global conditions allow in a manner that should not be considered unique to Earth.
"In short, our framework shows how hard steps may not actually exist - past evolutionary transitions that needed to happen for us humans to be here may not have been hard or unlikely in the available time," said Dan Mills, a postdoctoral researcher in geomicrobiology at the University of Munich and lead author of the study published on Friday in the journal Science Advances, opens new tab.
Physicist Brandon Carter devised the hard steps theory. It stresses that the long road to the emergence of humankind necessitated passage through various intermediate steps, each highly unlikely.
Over the years, scientists have tried to identify some of these hard steps. These include the emergence of single-celled living organisms on primordial Earth, the initial oxygenation of the atmosphere by photosynthesis, the evolutionary transition from prokaryotic cells that lack a nucleus and other internal structures to eukaryotic cells that have them, and the appearance of complex organisms such as multicellular animals. And then, the final proposed hard step is the appearance of Homo sapiens and milestones such as language and technology.
A species with advanced technological capabilities emerged on Earth relatively late in the Earth's habitable history, with the sun expected to increase in luminosity and boil away our planet's oceans about a billion years from now. This has inspired the argument that Earth is an incredibly rare planet that managed to accomplish the needed hard steps before becoming rendered uninhabitable.
The new theory was devised by a team of two geobiologists and two astronomers.
They propose that humankind's emergence followed the sequential opening of various "windows of habitability" over Earth's history, driven by factors such as changes in nutrient availability, sea surface temperatures, ocean salinity levels and atmospheric oxygen levels. Due to these factors, Earth only relatively recently became hospitable to a species like ours, they said, and that once those conditions existed the evolutionary path was relatively rapid.
"Biological innovations proposed as hard or unlikely might actually occur quickly - geologically speaking - as soon as the environment permits," said Penn State microbiologist Jennifer Macalady, one of the researchers.
"For example, life might have originated very quickly once temperatures were appropriate for the stability of biomolecules and liquid water. The Earth has only been habitable for humans since the second rise of oxygen in the atmosphere approximately 0.5 billion years ago, meaning that humans could not have evolved on Earth prior to that relatively recent moment," Macalady added.
Astronomers are searching for evidence of life beyond Earth and have identified roughly 5,800 exoplanets - planets beyond our solar system. Some of them are uninhabitable gas giants akin to Jupiter but some of them are rocky worlds like our solar system's four terrestrial planets that include Earth.
Astrophysicist and study co-author Jason Wright, director of the Penn State Extraterrestrial Intelligence Center, said that a best estimate right now is that somewhere around half of stars have a planet about the size of Earth orbiting at about the right distance to host liquid water, a key ingredient for life.
"Understanding the probability of intelligent life emerging helps us understand our own place in the world," Mills said. "Are we humans a cosmic fluke, as the hard steps model predicts? Or are we instead the more expected and typical outcome of a living planet, as our alternative framework suggests?"
here.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scottish Sun
21 hours ago
- Scottish Sun
‘Game changing' fat jabs WON'T help you lose as much weight as you think, scientists discover
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SO-CALLED 'miracle' weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits considering the injections, which have soared in popularity across the UK in recent years. Sign up for Scottish Sun newsletter Sign up 2 In a 'real-world' setting people might lose less weight in a regular clinical setting than during clinical trials Credit: Alamy 2 The drugs work best when people stick to them and take the full recommended dose Credit: Reuters Until now, the jabs have been hailed as an easier alternative to classic weight loss methods like calorie counting, weight watchers and the gym. But researchers at the Cleveland Clinic in the US found average weight loss on the jabs in the 'real world' is just 6.9 per cent after a year. This is less than half the amount typically seen in clinical trials, where patients often lose 15 per cent with semaglutide, the ingredient in Wegovy, and up to 22.5 per cent with tirzepatide, found in Mounjaro. The study, published on Tuesday in Obesity, followed 7,881 adults with severe obesity who started semaglutide or tirzepatide between 2021 and 2023. It discovered the drugs worked best when people stuck to them and took the full recommended dose, but in the real world, that rarely happened. More than one in five patients (21 per cent) stopped taking the jabs within the first three months, and another 32 per cent quit between three and 12 months. Meanwhile, over 80 per cent were on lower-than-recommended maintenance doses, needed to keep the weight off. Those who quit early lost just 3.6 per cent of their body weight. Patients who stayed on the treatment for a full year lost 11.9 per cent on average. The best results were seen in people who stayed on full doses, who lost 13.7 per cent with semaglutide and 18 per cent with tirzepatide. GP-approved tips to really lose weight safely - and keep it off 'Our findings could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions," Dr Hamlet Gasoyan, lead author of the study, said. Among the 1,320 people with prediabetes, the precursor to type 2 diabetes, at the start of the study, those who stayed on the jabs were also far more likely to reverse the condition. Don't stop the drugs early These medications work by copying a natural hormone found in the body called GLP-1. This hormone helps people feel fuller for longer, which reduces appetite and helps with weight loss. It also helps control blood sugar by telling the pancreas to make more insulin and slowing down how quickly sugar from food gets into the bloodstream. That's why these drugs are effective at both preventing type 2 diabetes and helping people shed pounds. Just 33 per cent of early quitters returned to normal blood sugar levels, compared with 68 per cent of those who stayed on the medication. 'Type 2 diabetes is one of the most common complications of obesity, so diabetes prevention is very important,' Dr Gasoyan said. 'This study highlights that treatment discontinuation, especially early, negatively affects both weight and glycemic control outcomes.' The most common reasons for stopping the jabs were cost, insurance issues, side effects and shortages, it said, The experts said a follow-up study is planned to dig deeper into why patients quit, and what happens to their weight afterwards.


Reuters
2 days ago
- Reuters
Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study
June 11 (Reuters) - Novavax's (NVAX.O), opens new tab experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.


Economist
2 days ago
- Economist
Africa's architectural movement will benefit the world
A handpicked article read aloud from the latest issue of The Economist. A new generation of African architects are looking to nature for inspiration to create climate-friendly buildings, and doing so on the cheap. Their innovations are getting noticed abroad, while their influence is spreading.